Psychopharmacology and Psychiatry Updates
En podcast av Psychopharmacology Institute
Kategorier:
252 Avsnitt
-
Antipsychotics for First Episodes of Psychosis
Publicerades: 2022-04-12 -
Effects on Suicidal Risk With Different Medications
Publicerades: 2022-04-07 -
Risks of Using Cannabinoids
Publicerades: 2022-04-02 -
Lithium: How to Manage Dosage
Publicerades: 2022-03-28 -
CBD as a Medication
Publicerades: 2022-03-23 -
SSRIs and Suicidality
Publicerades: 2022-03-18 -
Cannabis and Cognition
Publicerades: 2022-03-13 -
Clozapine-Induced Myocarditis
Publicerades: 2022-03-08 -
Does Cannabis Use Cause Psychiatric Disorders?
Publicerades: 2022-03-03 -
Treatment Strategies for Treatment-Resistant OCD
Publicerades: 2022-02-26 -
Lithium Augmentation for Psychotic Depression
Publicerades: 2022-02-21 -
Prevention and Treatment Strategies for Agitation and Dementia
Publicerades: 2022-02-16 -
Choosing an Antipsychotic for Psychotic Depression
Publicerades: 2022-02-11 -
Neurological and Psychiatric Sequelae Due to COVID-19
Publicerades: 2022-02-06 -
SNRIs + Antipsychotics for Psychotic Depression
Publicerades: 2022-02-01 -
Approaches for Addressing Tobacco Use Disorder
Publicerades: 2022-01-27 -
ECT the First-Choice Treatment for Psychotic Depression
Publicerades: 2022-01-22 -
Metabolic Characteristics of Newer Second-Generation Antipsychotics
Publicerades: 2022-01-17 -
Prescribing Antipsychotics During Breastfeeding
Publicerades: 2022-01-12 -
Fluvoxamine for Treating COVID-19
Publicerades: 2022-01-07
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.